Strong Buy
Buy
Hold
Sell
Strong Sell
Consensus
| Date | Grading Company | New Grade | Previous Grade | Action | Price When Posted | News Title | Publisher |
|---|---|---|---|---|---|---|---|
| 2026-07-21 | Roth Capital | Buy | Buy | Hold | $3.86 | Roth says Azurity deal validates D-PLEX100, sees limited ne… | TheFly |
| 2025-12-01 | Citigroup | Market Outperform | Market Outperform | Hold | $3.945 | PolyPid's (PYPD) DPLEX100 Demonstrates Positive Phase 3 Res… | StreetInsider |
| 2025-08-14 | Craig-Hallum | Buy | Buy | Hold | $3.43 | PolyPid price target lowered to $13 from $15 at Craig-Hallum | TheFly |
| 2025-08-14 | Roth Capital | Buy | Buy | Hold | $3.59 | PolyPid price target raised to $10 from $9 at Roth Capital | TheFly |
| 2025-06-17 | Roth Capital | Buy | Buy | Hold | $3.53 | PolyPid price target lowered to $9 from $12 at Roth Capital | TheFly |
| 2024-11-04 | Craig-Hallum | Buy | N/A | Initialise | $3.33 | Craig-Hallum Starts PolyPid Ltd. (PYPD) at Buy | StreetInsider |
| 2022-09-06 | Raymond James | Outperform | N/A | Downgrade | $36 | This Analyst Sees Recovery For PolyPid Despite Failed Phase… | Benzinga |
| 2022-09-02 | Guggenheim | Neutral | N/A | Upgrade | $42.3 | Pre-Open Movers: lululemon Ramps on Strong Results, PolyPid… | Investing |
| 2022-08-11 | BMO Capital | Outperform | Outperform | Hold | $181.79999999999998 | BMO Capital Maintains Outperform on PolyPid, Lowers Price T… | Benzinga |